The first FDA approved flouroquinolone for the treatment of bovine respiratory disease (BRD), this antibiotic reaches therapeutic levels at the site of infection in the lungs in 1 to 2 hours. Injects easily even in cold weather and has no significant injection site reactions.
For the treatment of bovine respiratory disease (BRD) caused by Mannheimia haemolytica, Pasteurella multocida, and Haemophilus somnus
Labeled for: beef and dairy cattle under 20 months of age
Species: cattle, calf, horse
What others are saying
There are no contributions yet.